Professional
Added to YB: 2025-10-23
Pitch date: 2025-10-06
MEDP [neutral]
Medpace Holdings, Inc.
-6.58%
current return
Author Info
No bio for this author
Company Info
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
Market Cap
$12.8B
Pitch Price
$530.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
20.52
P/E
29.53
EV/Sales
4.92
Sector
Life Sciences Tools and Services
Category
value
Giverny Capital Asset Management Portfolio Holding: Medpace Holdings, Inc.
MEDP (holding update): CRO for early-stage biopharma clinical trials. Stock dropped from $381 to ~$300 on RFK Jr./FDA concerns, management bought back 9% of shares at depressed prices. Founder Troendle ($2.8B net worth) investing in growth. Q2 earnings drove 50%+ single-day gain to $514 close.
Read full article (2 min)